Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Clinical trial NCT02147873 · TERMINATED

Trial details

NCT number: NCT02147873
Sponsor: TetraLogic Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)

Start date: 2014-06-01
Primary completion: 2016-01-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.